|
1
|
-
"Congratulate ！The high-quality article performs well in terms of objectivity, credibility, and scientific quality. Thank you for your support of World Journal of Experimental Medicine. Looking forward to your next originality and innovativeness.
Impact Factors of Baishideng Series of Journals released in 2024:
World Journal of Gastroenterology (2024 released IF: 4.3, Quartile: Q1; CiteScore: 7.8)
World Journal of Diabetes (2024 released IF: 4.2, Quartile: Q1)
World Journal of Psychiatry (2024 released IF: 3.9, Quartile: Q1)
World Journal of Gastrointestinal Oncology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.2)
World Journal of Hepatology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.1)
World Journal of Orthopedics (2024 released IF: 2.0, Quartile: Q2; CiteScore: 3.1)
World Journal of Gastrointestinal Surgery (2024 released IF: 1.8, Quartile: Q2)
World Journal of Stem Cells (2024 released IF: 3.6, Quartile: Q3; CiteScore: 7.8)
World Journal of Clinical Oncology (2024 released IF: 2.6, Quartile: Q3)
World Journal of Cardiology (2024 released IF: 1.9, Quartile: Q3; CiteScore: 3.3)
World Journal of Radiology (2024 released IF: 1.4, Quartile: Q3)
World Journal of Gastrointestinal Endoscopy (2024 released IF: 1.4, Quartile: Q4)"
-
Senchukova MA, Saidler NV, Zubareva EY, Prokofiev AB, Tagabilev DG. Concordance of programmed death-ligand 1 expression assessments determined via two immunohistochemical tests and the polymerase chain reaction method. World J Exp Med 2025; 15(3): 108984 [DOI: 10.5493/wjem.v15.i3.108984]
|
|
2
|
-
"Congratulate ！The high-quality article performs well in terms of objectivity, credibility, and scientific quality. Thank you for your support of World Journal of Experimental Medicine. Looking forward to your next originality and innovativeness.
Impact Factors of Baishideng Series of Journals released in 2024:
World Journal of Gastroenterology (2024 released IF: 4.3, Quartile: Q1; CiteScore: 7.8)
World Journal of Diabetes (2024 released IF: 4.2, Quartile: Q1)
World Journal of Psychiatry (2024 released IF: 3.9, Quartile: Q1)
World Journal of Gastrointestinal Oncology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.2)
World Journal of Hepatology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.1)
World Journal of Orthopedics (2024 released IF: 2.0, Quartile: Q2; CiteScore: 3.1)
World Journal of Gastrointestinal Surgery (2024 released IF: 1.8, Quartile: Q2)
World Journal of Stem Cells (2024 released IF: 3.6, Quartile: Q3; CiteScore: 7.8)
World Journal of Clinical Oncology (2024 released IF: 2.6, Quartile: Q3)
World Journal of Cardiology (2024 released IF: 1.9, Quartile: Q3; CiteScore: 3.3)
World Journal of Radiology (2024 released IF: 1.4, Quartile: Q3)
World Journal of Gastrointestinal Endoscopy (2024 released IF: 1.4, Quartile: Q4)"
-
Dubey VP, Kansagra JJ, Kamani BK, Sureja VP. Triple probiotic combination effect on metabolic, oxidative stress, and inflammatory parameters in diabetic population: Systematic review and meta-analysis. World J Exp Med 2025; 15(3): 108467 [DOI: 10.5493/wjem.v15.i3.108467]
|
|
3
|
-
"Congratulate ！The high-quality article performs well in terms of objectivity, credibility, and scientific quality. Thank you for your support of World Journal of Experimental Medicine. Looking forward to your next originality and innovativeness.
Impact Factors of Baishideng Series of Journals released in 2024:
World Journal of Gastroenterology (2024 released IF: 4.3, Quartile: Q1; CiteScore: 7.8)
World Journal of Diabetes (2024 released IF: 4.2, Quartile: Q1)
World Journal of Psychiatry (2024 released IF: 3.9, Quartile: Q1)
World Journal of Gastrointestinal Oncology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.2)
World Journal of Hepatology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.1)
World Journal of Orthopedics (2024 released IF: 2.0, Quartile: Q2; CiteScore: 3.1)
World Journal of Gastrointestinal Surgery (2024 released IF: 1.8, Quartile: Q2)
World Journal of Stem Cells (2024 released IF: 3.6, Quartile: Q3; CiteScore: 7.8)
World Journal of Clinical Oncology (2024 released IF: 2.6, Quartile: Q3)
World Journal of Cardiology (2024 released IF: 1.9, Quartile: Q3; CiteScore: 3.3)
World Journal of Radiology (2024 released IF: 1.4, Quartile: Q3)
World Journal of Gastrointestinal Endoscopy (2024 released IF: 1.4, Quartile: Q4)"
-
Ozer SP, Keyif F, Bolat F, Ozer B, Aktas G. Relationship of diabetes mellitus with prognostic factors in breast cancer. World J Exp Med 2025; 15(3): 108318 [DOI: 10.5493/wjem.v15.i3.108318]
|
|
4
|
-
"Congratulate ！The high-quality article performs well in terms of objectivity, credibility, and scientific quality. Thank you for your support of World Journal of Experimental Medicine. Looking forward to your next originality and innovativeness.
Impact Factors of Baishideng Series of Journals released in 2024:
World Journal of Gastroenterology (2024 released IF: 4.3, Quartile: Q1; CiteScore: 7.8)
World Journal of Diabetes (2024 released IF: 4.2, Quartile: Q1)
World Journal of Psychiatry (2024 released IF: 3.9, Quartile: Q1)
World Journal of Gastrointestinal Oncology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.2)
World Journal of Hepatology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.1)
World Journal of Orthopedics (2024 released IF: 2.0, Quartile: Q2; CiteScore: 3.1)
World Journal of Gastrointestinal Surgery (2024 released IF: 1.8, Quartile: Q2)
World Journal of Stem Cells (2024 released IF: 3.6, Quartile: Q3; CiteScore: 7.8)
World Journal of Clinical Oncology (2024 released IF: 2.6, Quartile: Q3)
World Journal of Cardiology (2024 released IF: 1.9, Quartile: Q3; CiteScore: 3.3)
World Journal of Radiology (2024 released IF: 1.4, Quartile: Q3)
World Journal of Gastrointestinal Endoscopy (2024 released IF: 1.4, Quartile: Q4)"
-
El-Toukhy SE, Nabih HK, Kamel MM, Elmasry H, El-Daly SM. Circulating microRNAs and serum proteins in breast cancer patients: Diagnostic relevance and grade-specific expression patterns. World J Exp Med 2025; 15(3): 108034 [DOI: 10.5493/wjem.v15.i3.108034]
|
|
5
|
-
"Congratulate ！The high-quality article performs well in terms of objectivity, credibility, and scientific quality. Thank you for your support of World Journal of Experimental Medicine. Looking forward to your next originality and innovativeness.
Impact Factors of Baishideng Series of Journals released in 2024:
World Journal of Gastroenterology (2024 released IF: 4.3, Quartile: Q1; CiteScore: 7.8)
World Journal of Diabetes (2024 released IF: 4.2, Quartile: Q1)
World Journal of Psychiatry (2024 released IF: 3.9, Quartile: Q1)
World Journal of Gastrointestinal Oncology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.2)
World Journal of Hepatology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.1)
World Journal of Orthopedics (2024 released IF: 2.0, Quartile: Q2; CiteScore: 3.1)
World Journal of Gastrointestinal Surgery (2024 released IF: 1.8, Quartile: Q2)
World Journal of Stem Cells (2024 released IF: 3.6, Quartile: Q3; CiteScore: 7.8)
World Journal of Clinical Oncology (2024 released IF: 2.6, Quartile: Q3)
World Journal of Cardiology (2024 released IF: 1.9, Quartile: Q3; CiteScore: 3.3)
World Journal of Radiology (2024 released IF: 1.4, Quartile: Q3)
World Journal of Gastrointestinal Endoscopy (2024 released IF: 1.4, Quartile: Q4)"
-
Álvarez-Martínez E, Porto-Puerta IE, Ardila CM. Genotoxic damage assessment using the micronucleus assay in buccal mucosa of different types of smokers: A cross-sectional study. World J Exp Med 2025; 15(3): 108025 [DOI: 10.5493/wjem.v15.i3.108025]
|
|
6
|
-
"Congratulate ！The high-quality article performs well in terms of objectivity, credibility, and scientific quality. Thank you for your support of World Journal of Experimental Medicine. Looking forward to your next originality and innovativeness.
Impact Factors of Baishideng Series of Journals released in 2024:
World Journal of Gastroenterology (2024 released IF: 4.3, Quartile: Q1; CiteScore: 7.8)
World Journal of Diabetes (2024 released IF: 4.2, Quartile: Q1)
World Journal of Psychiatry (2024 released IF: 3.9, Quartile: Q1)
World Journal of Gastrointestinal Oncology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.2)
World Journal of Hepatology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.1)
World Journal of Orthopedics (2024 released IF: 2.0, Quartile: Q2; CiteScore: 3.1)
World Journal of Gastrointestinal Surgery (2024 released IF: 1.8, Quartile: Q2)
World Journal of Stem Cells (2024 released IF: 3.6, Quartile: Q3; CiteScore: 7.8)
World Journal of Clinical Oncology (2024 released IF: 2.6, Quartile: Q3)
World Journal of Cardiology (2024 released IF: 1.9, Quartile: Q3; CiteScore: 3.3)
World Journal of Radiology (2024 released IF: 1.4, Quartile: Q3)
World Journal of Gastrointestinal Endoscopy (2024 released IF: 1.4, Quartile: Q4)"
-
Ibrahim NH, Abdellateif MS, Serag DS, Laymouna A, Elaguizy MS, Halim RMA. Clinical significance of differential plasma proteins levels in the diagnosis of epithelial ovarian cancer. World J Exp Med 2025; 15(3): 107711 [DOI: 10.5493/wjem.v15.i3.107711]
|
|
7
|
-
"Congratulate ！The high-quality article performs well in terms of objectivity, credibility, and scientific quality. Thank you for your support of World Journal of Experimental Medicine. Looking forward to your next originality and innovativeness.
Impact Factors of Baishideng Series of Journals released in 2024:
World Journal of Gastroenterology (2024 released IF: 4.3, Quartile: Q1; CiteScore: 7.8)
World Journal of Diabetes (2024 released IF: 4.2, Quartile: Q1)
World Journal of Psychiatry (2024 released IF: 3.9, Quartile: Q1)
World Journal of Gastrointestinal Oncology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.2)
World Journal of Hepatology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.1)
World Journal of Orthopedics (2024 released IF: 2.0, Quartile: Q2; CiteScore: 3.1)
World Journal of Gastrointestinal Surgery (2024 released IF: 1.8, Quartile: Q2)
World Journal of Stem Cells (2024 released IF: 3.6, Quartile: Q3; CiteScore: 7.8)
World Journal of Clinical Oncology (2024 released IF: 2.6, Quartile: Q3)
World Journal of Cardiology (2024 released IF: 1.9, Quartile: Q3; CiteScore: 3.3)
World Journal of Radiology (2024 released IF: 1.4, Quartile: Q3)
World Journal of Gastrointestinal Endoscopy (2024 released IF: 1.4, Quartile: Q4)"
-
Rangarajan RV, Devadas AG, Padmanapan DJ, Jeyaraman N, Ramasubramanian S, Nallakumarasamy A, Muthu S, Jeyaraman M. Safety and efficacy of autologous bone marrow aspirate concentrate injection for idiopathic male infertility: A comparative study. World J Exp Med 2025; 15(3): 107323 [DOI: 10.5493/wjem.v15.i3.107323]
|
|
8
|
-
"Congratulate ！The high-quality article performs well in terms of objectivity, credibility, and scientific quality. Thank you for your support of World Journal of Experimental Medicine. Looking forward to your next originality and innovativeness.
Impact Factors of Baishideng Series of Journals released in 2024:
World Journal of Gastroenterology (2024 released IF: 4.3, Quartile: Q1; CiteScore: 7.8)
World Journal of Diabetes (2024 released IF: 4.2, Quartile: Q1)
World Journal of Psychiatry (2024 released IF: 3.9, Quartile: Q1)
World Journal of Gastrointestinal Oncology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.2)
World Journal of Hepatology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.1)
World Journal of Orthopedics (2024 released IF: 2.0, Quartile: Q2; CiteScore: 3.1)
World Journal of Gastrointestinal Surgery (2024 released IF: 1.8, Quartile: Q2)
World Journal of Stem Cells (2024 released IF: 3.6, Quartile: Q3; CiteScore: 7.8)
World Journal of Clinical Oncology (2024 released IF: 2.6, Quartile: Q3)
World Journal of Cardiology (2024 released IF: 1.9, Quartile: Q3; CiteScore: 3.3)
World Journal of Radiology (2024 released IF: 1.4, Quartile: Q3)
World Journal of Gastrointestinal Endoscopy (2024 released IF: 1.4, Quartile: Q4)"
-
Thiravialingam A, Sriganeshan K, Bahmad HF, Polit F, Ahmed A, Joshi D, Poppiti R. Incidental gallbladder mucocele mimicking acute cholecystitis: A case report and review of literature. World J Exp Med 2025; 15(3): 107248 [DOI: 10.5493/wjem.v15.i3.107248]
|
|
9
|
-
"Congratulate ！The high-quality article performs well in terms of objectivity, credibility, and scientific quality. Thank you for your support of World Journal of Experimental Medicine. Looking forward to your next originality and innovativeness.
Impact Factors of Baishideng Series of Journals released in 2024:
World Journal of Gastroenterology (2024 released IF: 4.3, Quartile: Q1; CiteScore: 7.8)
World Journal of Diabetes (2024 released IF: 4.2, Quartile: Q1)
World Journal of Psychiatry (2024 released IF: 3.9, Quartile: Q1)
World Journal of Gastrointestinal Oncology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.2)
World Journal of Hepatology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.1)
World Journal of Orthopedics (2024 released IF: 2.0, Quartile: Q2; CiteScore: 3.1)
World Journal of Gastrointestinal Surgery (2024 released IF: 1.8, Quartile: Q2)
World Journal of Stem Cells (2024 released IF: 3.6, Quartile: Q3; CiteScore: 7.8)
World Journal of Clinical Oncology (2024 released IF: 2.6, Quartile: Q3)
World Journal of Cardiology (2024 released IF: 1.9, Quartile: Q3; CiteScore: 3.3)
World Journal of Radiology (2024 released IF: 1.4, Quartile: Q3)
World Journal of Gastrointestinal Endoscopy (2024 released IF: 1.4, Quartile: Q4)"
-
Silvestri C, Stasi C, Profili F, Bartolacci S, Sessa E, Tacconi D, Villari L, Carrozzi L, Dotta F, Bargagli E, Donnini S, Masotti L, Rasero L, Lavorini F, Pistelli F, Chimera D, Sorano A, D'alessandro M, Pacifici M, Milli C, Voller F. Evaluation of short and long-term laboratory and instrumental findings in COVID-19 patients hospitalized in Tuscany. World J Exp Med 2025; 15(3): 107220 [DOI: 10.5493/wjem.v15.i3.107220]
|
|
10
|
-
"Congratulate ！The high-quality article performs well in terms of objectivity, credibility, and scientific quality. Thank you for your support of World Journal of Experimental Medicine. Looking forward to your next originality and innovativeness.
Impact Factors of Baishideng Series of Journals released in 2024:
World Journal of Gastroenterology (2024 released IF: 4.3, Quartile: Q1; CiteScore: 7.8)
World Journal of Diabetes (2024 released IF: 4.2, Quartile: Q1)
World Journal of Psychiatry (2024 released IF: 3.9, Quartile: Q1)
World Journal of Gastrointestinal Oncology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.2)
World Journal of Hepatology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.1)
World Journal of Orthopedics (2024 released IF: 2.0, Quartile: Q2; CiteScore: 3.1)
World Journal of Gastrointestinal Surgery (2024 released IF: 1.8, Quartile: Q2)
World Journal of Stem Cells (2024 released IF: 3.6, Quartile: Q3; CiteScore: 7.8)
World Journal of Clinical Oncology (2024 released IF: 2.6, Quartile: Q3)
World Journal of Cardiology (2024 released IF: 1.9, Quartile: Q3; CiteScore: 3.3)
World Journal of Radiology (2024 released IF: 1.4, Quartile: Q3)
World Journal of Gastrointestinal Endoscopy (2024 released IF: 1.4, Quartile: Q4)"
-
Singh H, Patel AA, Pandy P, Omar BJ, Prasad A, Singh V, Sharma P, Bairwa M, Sihag RK, Tiwari A, Rajput D, Kulshrestha M, Saini S, Kumar A, Sarkar B, Duggal B, Agarwal A, Kaeley N, Dhingra G, Mahala P, Yesodharan V, Chauhan H, Kumari D, Choudhary S, Sharma AK, Yadav R, Panda PK. Burden of multi-drug-resistant organisms in a tertiary healthcare institute in North India: Implications for regional public health. World J Exp Med 2025; 15(3): 107184 [DOI: 10.5493/wjem.v15.i3.107184]
|
|
11
|
-
"Congratulate ！The high-quality article performs well in terms of objectivity, credibility, and scientific quality. Thank you for your support of World Journal of Experimental Medicine. Looking forward to your next originality and innovativeness.
Impact Factors of Baishideng Series of Journals released in 2024:
World Journal of Gastroenterology (2024 released IF: 4.3, Quartile: Q1; CiteScore: 7.8)
World Journal of Diabetes (2024 released IF: 4.2, Quartile: Q1)
World Journal of Psychiatry (2024 released IF: 3.9, Quartile: Q1)
World Journal of Gastrointestinal Oncology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.2)
World Journal of Hepatology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.1)
World Journal of Orthopedics (2024 released IF: 2.0, Quartile: Q2; CiteScore: 3.1)
World Journal of Gastrointestinal Surgery (2024 released IF: 1.8, Quartile: Q2)
World Journal of Stem Cells (2024 released IF: 3.6, Quartile: Q3; CiteScore: 7.8)
World Journal of Clinical Oncology (2024 released IF: 2.6, Quartile: Q3)
World Journal of Cardiology (2024 released IF: 1.9, Quartile: Q3; CiteScore: 3.3)
World Journal of Radiology (2024 released IF: 1.4, Quartile: Q3)
World Journal of Gastrointestinal Endoscopy (2024 released IF: 1.4, Quartile: Q4)"
-
Chamchoum E, Katrib N, Nassif N, Ratel Y, Rida MA. Glucagon-like peptide and its receptor agonists for the treatment of rheumatic diseases. World J Exp Med 2025; 15(3): 107020 [DOI: 10.5493/wjem.v15.i3.107020]
|
|
12
|
-
"Congratulate ！The high-quality article performs well in terms of objectivity, credibility, and scientific quality. Thank you for your support of World Journal of Experimental Medicine. Looking forward to your next originality and innovativeness.
Impact Factors of Baishideng Series of Journals released in 2024:
World Journal of Gastroenterology (2024 released IF: 4.3, Quartile: Q1; CiteScore: 7.8)
World Journal of Diabetes (2024 released IF: 4.2, Quartile: Q1)
World Journal of Psychiatry (2024 released IF: 3.9, Quartile: Q1)
World Journal of Gastrointestinal Oncology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.2)
World Journal of Hepatology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.1)
World Journal of Orthopedics (2024 released IF: 2.0, Quartile: Q2; CiteScore: 3.1)
World Journal of Gastrointestinal Surgery (2024 released IF: 1.8, Quartile: Q2)
World Journal of Stem Cells (2024 released IF: 3.6, Quartile: Q3; CiteScore: 7.8)
World Journal of Clinical Oncology (2024 released IF: 2.6, Quartile: Q3)
World Journal of Cardiology (2024 released IF: 1.9, Quartile: Q3; CiteScore: 3.3)
World Journal of Radiology (2024 released IF: 1.4, Quartile: Q3)
World Journal of Gastrointestinal Endoscopy (2024 released IF: 1.4, Quartile: Q4)"
-
Martín Giménez VM, García Menéndez S, Sanz RL, Schiavone M, Ferder L, Inserra F, Manucha W. Potential role of nanopharmacology in reducing neuroinflammation associated with hypertension and metabolic disorders. World J Exp Med 2025; 15(3): 106743 [DOI: 10.5493/wjem.v15.i3.106743]
|
|
13
|
-
"Congratulate ！The high-quality article performs well in terms of objectivity, credibility, and scientific quality. Thank you for your support of World Journal of Experimental Medicine. Looking forward to your next originality and innovativeness.
Impact Factors of Baishideng Series of Journals released in 2024:
World Journal of Gastroenterology (2024 released IF: 4.3, Quartile: Q1; CiteScore: 7.8)
World Journal of Diabetes (2024 released IF: 4.2, Quartile: Q1)
World Journal of Psychiatry (2024 released IF: 3.9, Quartile: Q1)
World Journal of Gastrointestinal Oncology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.2)
World Journal of Hepatology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.1)
World Journal of Orthopedics (2024 released IF: 2.0, Quartile: Q2; CiteScore: 3.1)
World Journal of Gastrointestinal Surgery (2024 released IF: 1.8, Quartile: Q2)
World Journal of Stem Cells (2024 released IF: 3.6, Quartile: Q3; CiteScore: 7.8)
World Journal of Clinical Oncology (2024 released IF: 2.6, Quartile: Q3)
World Journal of Cardiology (2024 released IF: 1.9, Quartile: Q3; CiteScore: 3.3)
World Journal of Radiology (2024 released IF: 1.4, Quartile: Q3)
World Journal of Gastrointestinal Endoscopy (2024 released IF: 1.4, Quartile: Q4)"
-
Qu RH, Rong Y, Ni WZ, Huang XL, Chen YZ, Li HF. Fibrinogen superfamily proteins: Key regulators in hepatic disorders. World J Exp Med 2025; 15(3): 106677 [DOI: 10.5493/wjem.v15.i3.106677]
|
|
14
|
-
"Congratulate ！The high-quality article performs well in terms of objectivity, credibility, and scientific quality. Thank you for your support of World Journal of Experimental Medicine. Looking forward to your next originality and innovativeness.
Impact Factors of Baishideng Series of Journals released in 2024:
World Journal of Gastroenterology (2024 released IF: 4.3, Quartile: Q1; CiteScore: 7.8)
World Journal of Diabetes (2024 released IF: 4.2, Quartile: Q1)
World Journal of Psychiatry (2024 released IF: 3.9, Quartile: Q1)
World Journal of Gastrointestinal Oncology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.2)
World Journal of Hepatology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.1)
World Journal of Orthopedics (2024 released IF: 2.0, Quartile: Q2; CiteScore: 3.1)
World Journal of Gastrointestinal Surgery (2024 released IF: 1.8, Quartile: Q2)
World Journal of Stem Cells (2024 released IF: 3.6, Quartile: Q3; CiteScore: 7.8)
World Journal of Clinical Oncology (2024 released IF: 2.6, Quartile: Q3)
World Journal of Cardiology (2024 released IF: 1.9, Quartile: Q3; CiteScore: 3.3)
World Journal of Radiology (2024 released IF: 1.4, Quartile: Q3)
World Journal of Gastrointestinal Endoscopy (2024 released IF: 1.4, Quartile: Q4)"
-
Choudhery MS, Arif T, Afzal A, Mahmood R. Therapeutic potential of adipose tissue in aesthetic medicine. World J Exp Med 2025; 15(3): 106641 [DOI: 10.5493/wjem.v15.i3.106641]
|
|
15
|
-
"Congratulate ！The high-quality article performs well in terms of objectivity, credibility, and scientific quality. Thank you for your support of World Journal of Experimental Medicine. Looking forward to your next originality and innovativeness.
Impact Factors of Baishideng Series of Journals released in 2024:
World Journal of Gastroenterology (2024 released IF: 4.3, Quartile: Q1; CiteScore: 7.8)
World Journal of Diabetes (2024 released IF: 4.2, Quartile: Q1)
World Journal of Psychiatry (2024 released IF: 3.9, Quartile: Q1)
World Journal of Gastrointestinal Oncology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.2)
World Journal of Hepatology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.1)
World Journal of Orthopedics (2024 released IF: 2.0, Quartile: Q2; CiteScore: 3.1)
World Journal of Gastrointestinal Surgery (2024 released IF: 1.8, Quartile: Q2)
World Journal of Stem Cells (2024 released IF: 3.6, Quartile: Q3; CiteScore: 7.8)
World Journal of Clinical Oncology (2024 released IF: 2.6, Quartile: Q3)
World Journal of Cardiology (2024 released IF: 1.9, Quartile: Q3; CiteScore: 3.3)
World Journal of Radiology (2024 released IF: 1.4, Quartile: Q3)
World Journal of Gastrointestinal Endoscopy (2024 released IF: 1.4, Quartile: Q4)"
-
Wong LW, Lam WY, Au SCL. Systematic review and risk factor analysis of post-vitrectomy silicone oil migration to the central nervous system. World J Exp Med 2025; 15(3): 106429 [DOI: 10.5493/wjem.v15.i3.106429]
|
|
16
|
-
"Congratulate ！The high-quality article performs well in terms of objectivity, credibility, and scientific quality. Thank you for your support of World Journal of Experimental Medicine. Looking forward to your next originality and innovativeness.
Impact Factors of Baishideng Series of Journals released in 2024:
World Journal of Gastroenterology (2024 released IF: 4.3, Quartile: Q1; CiteScore: 7.8)
World Journal of Diabetes (2024 released IF: 4.2, Quartile: Q1)
World Journal of Psychiatry (2024 released IF: 3.9, Quartile: Q1)
World Journal of Gastrointestinal Oncology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.2)
World Journal of Hepatology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.1)
World Journal of Orthopedics (2024 released IF: 2.0, Quartile: Q2; CiteScore: 3.1)
World Journal of Gastrointestinal Surgery (2024 released IF: 1.8, Quartile: Q2)
World Journal of Stem Cells (2024 released IF: 3.6, Quartile: Q3; CiteScore: 7.8)
World Journal of Clinical Oncology (2024 released IF: 2.6, Quartile: Q3)
World Journal of Cardiology (2024 released IF: 1.9, Quartile: Q3; CiteScore: 3.3)
World Journal of Radiology (2024 released IF: 1.4, Quartile: Q3)
World Journal of Gastrointestinal Endoscopy (2024 released IF: 1.4, Quartile: Q4)"
-
Nallakumarasamy A, Shrivastava S, Rangarajan RV, Jeyaraman N, Ramasubramanian S, Muthu S, Jeyaraman M. Comparative outcome analyses of subchondral vs intra-articular bone marrow aspirate concentrate in primary osteoarthritis knee: A double-blinded randomized controlled trial protocol. World J Exp Med 2025; 15(3): 106020 [DOI: 10.5493/wjem.v15.i3.106020]
|
|
17
|
-
"Congratulate ！The high-quality article performs well in terms of objectivity, credibility, and scientific quality. Thank you for your support of World Journal of Experimental Medicine. Looking forward to your next originality and innovativeness.
Impact Factors of Baishideng Series of Journals released in 2024:
World Journal of Gastroenterology (2024 released IF: 4.3, Quartile: Q1; CiteScore: 7.8)
World Journal of Diabetes (2024 released IF: 4.2, Quartile: Q1)
World Journal of Psychiatry (2024 released IF: 3.9, Quartile: Q1)
World Journal of Gastrointestinal Oncology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.2)
World Journal of Hepatology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.1)
World Journal of Orthopedics (2024 released IF: 2.0, Quartile: Q2; CiteScore: 3.1)
World Journal of Gastrointestinal Surgery (2024 released IF: 1.8, Quartile: Q2)
World Journal of Stem Cells (2024 released IF: 3.6, Quartile: Q3; CiteScore: 7.8)
World Journal of Clinical Oncology (2024 released IF: 2.6, Quartile: Q3)
World Journal of Cardiology (2024 released IF: 1.9, Quartile: Q3; CiteScore: 3.3)
World Journal of Radiology (2024 released IF: 1.4, Quartile: Q3)
World Journal of Gastrointestinal Endoscopy (2024 released IF: 1.4, Quartile: Q4)"
-
Jeyaraman N, Shrivastava S, Rangarajan RV, Nallakumarasamy A, Ramasubramanian S, Muthu S, Jeyaraman M. Comparative outcome analyses of stromal vascular fraction vs nanofat in primary osteoarthritis knee: A double-blinded randomized controlled trial protocol. World J Exp Med 2025; 15(3): 105973 [DOI: 10.5493/wjem.v15.i3.105973]
|
|
18
|
-
"Congratulate ！The high-quality article performs well in terms of objectivity, credibility, and scientific quality. Thank you for your support of World Journal of Experimental Medicine. Looking forward to your next originality and innovativeness.
Impact Factors of Baishideng Series of Journals released in 2024:
World Journal of Gastroenterology (2024 released IF: 4.3, Quartile: Q1; CiteScore: 7.8)
World Journal of Diabetes (2024 released IF: 4.2, Quartile: Q1)
World Journal of Psychiatry (2024 released IF: 3.9, Quartile: Q1)
World Journal of Gastrointestinal Oncology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.2)
World Journal of Hepatology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.1)
World Journal of Orthopedics (2024 released IF: 2.0, Quartile: Q2; CiteScore: 3.1)
World Journal of Gastrointestinal Surgery (2024 released IF: 1.8, Quartile: Q2)
World Journal of Stem Cells (2024 released IF: 3.6, Quartile: Q3; CiteScore: 7.8)
World Journal of Clinical Oncology (2024 released IF: 2.6, Quartile: Q3)
World Journal of Cardiology (2024 released IF: 1.9, Quartile: Q3; CiteScore: 3.3)
World Journal of Radiology (2024 released IF: 1.4, Quartile: Q3)
World Journal of Gastrointestinal Endoscopy (2024 released IF: 1.4, Quartile: Q4)"
-
Kumar A, Kumar C, Kumar A, Kumari S, Aneela, Rai R, Kumar A, Kumar K, Gyaneshwari, Aslam H, Jawed I, Alam F, Rizvi SAFA, Umair M, Mirza AM. Management of anticoagulation in patients with atrial fibrillation and renal dysfunction: A systematic review. World J Exp Med 2025; 15(3): 105485 [DOI: 10.5493/wjem.v15.i3.105485]
|
|
19
|
-
"Congratulate ！The high-quality article performs well in terms of objectivity, credibility, and scientific quality. Thank you for your support of World Journal of Experimental Medicine. Looking forward to your next originality and innovativeness.
Impact Factors of Baishideng Series of Journals released in 2024:
World Journal of Gastroenterology (2024 released IF: 4.3, Quartile: Q1; CiteScore: 7.8)
World Journal of Diabetes (2024 released IF: 4.2, Quartile: Q1)
World Journal of Psychiatry (2024 released IF: 3.9, Quartile: Q1)
World Journal of Gastrointestinal Oncology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.2)
World Journal of Hepatology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.1)
World Journal of Orthopedics (2024 released IF: 2.0, Quartile: Q2; CiteScore: 3.1)
World Journal of Gastrointestinal Surgery (2024 released IF: 1.8, Quartile: Q2)
World Journal of Stem Cells (2024 released IF: 3.6, Quartile: Q3; CiteScore: 7.8)
World Journal of Clinical Oncology (2024 released IF: 2.6, Quartile: Q3)
World Journal of Cardiology (2024 released IF: 1.9, Quartile: Q3; CiteScore: 3.3)
World Journal of Radiology (2024 released IF: 1.4, Quartile: Q3)
World Journal of Gastrointestinal Endoscopy (2024 released IF: 1.4, Quartile: Q4)"
-
Das P, Chaudhary DK, Mishra R, Tiwari S. Evaluation of urinary extracellular vesicles and microRNAs to diagnose urogenital tuberculosis. World J Exp Med 2025; 15(3): 105208 [DOI: 10.5493/wjem.v15.i3.105208]
|
|
20
|
-
"Congratulate ！The high-quality article performs well in terms of objectivity, credibility, and scientific quality. Thank you for your support of World Journal of Experimental Medicine. Looking forward to your next originality and innovativeness.
Impact Factors of Baishideng Series of Journals released in 2024:
World Journal of Gastroenterology (2024 released IF: 4.3, Quartile: Q1; CiteScore: 7.8)
World Journal of Diabetes (2024 released IF: 4.2, Quartile: Q1)
World Journal of Psychiatry (2024 released IF: 3.9, Quartile: Q1)
World Journal of Gastrointestinal Oncology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.2)
World Journal of Hepatology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.1)
World Journal of Orthopedics (2024 released IF: 2.0, Quartile: Q2; CiteScore: 3.1)
World Journal of Gastrointestinal Surgery (2024 released IF: 1.8, Quartile: Q2)
World Journal of Stem Cells (2024 released IF: 3.6, Quartile: Q3; CiteScore: 7.8)
World Journal of Clinical Oncology (2024 released IF: 2.6, Quartile: Q3)
World Journal of Cardiology (2024 released IF: 1.9, Quartile: Q3; CiteScore: 3.3)
World Journal of Radiology (2024 released IF: 1.4, Quartile: Q3)
World Journal of Gastrointestinal Endoscopy (2024 released IF: 1.4, Quartile: Q4)"
-
Dabla PK, Upreti K, Singh D, Singh A, Puri V, Stanciu AE, Serdarevic N, Gruson D. Anti-epileptic medication induced disturbed calcium-vitamin D metabolism: A behavioral analysis using association rule mining technique. World J Exp Med 2025; 15(3): 104799 [DOI: 10.5493/wjem.v15.i3.104799]
|
|
21
|
-
"Congratulate ！The high-quality article performs well in terms of objectivity, credibility, and scientific quality. Thank you for your support of World Journal of Experimental Medicine. Looking forward to your next originality and innovativeness.
Impact Factors of Baishideng Series of Journals released in 2024:
World Journal of Gastroenterology (2024 released IF: 4.3, Quartile: Q1; CiteScore: 7.8)
World Journal of Diabetes (2024 released IF: 4.2, Quartile: Q1)
World Journal of Psychiatry (2024 released IF: 3.9, Quartile: Q1)
World Journal of Gastrointestinal Oncology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.2)
World Journal of Hepatology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.1)
World Journal of Orthopedics (2024 released IF: 2.0, Quartile: Q2; CiteScore: 3.1)
World Journal of Gastrointestinal Surgery (2024 released IF: 1.8, Quartile: Q2)
World Journal of Stem Cells (2024 released IF: 3.6, Quartile: Q3; CiteScore: 7.8)
World Journal of Clinical Oncology (2024 released IF: 2.6, Quartile: Q3)
World Journal of Cardiology (2024 released IF: 1.9, Quartile: Q3; CiteScore: 3.3)
World Journal of Radiology (2024 released IF: 1.4, Quartile: Q3)
World Journal of Gastrointestinal Endoscopy (2024 released IF: 1.4, Quartile: Q4)"
-
Garg G, Chaudhary S, Khatana K, Bharadwaj A. Flavonoids extract from Vitex negundo inhibit autophagy by targeting PI3K/AKT/mTOR/p70S6K/ULK signaling cascade in cancerous cells. World J Exp Med 2025; 15(3): 104678 [DOI: 10.5493/wjem.v15.i3.104678]
|
|
22
|
-
"Congratulate ！The high-quality article performs well in terms of objectivity, credibility, and scientific quality. Thank you for your support of World Journal of Experimental Medicine. Looking forward to your next originality and innovativeness.
Impact Factors of Baishideng Series of Journals released in 2024:
World Journal of Gastroenterology (2024 released IF: 4.3, Quartile: Q1; CiteScore: 7.8)
World Journal of Diabetes (2024 released IF: 4.2, Quartile: Q1)
World Journal of Psychiatry (2024 released IF: 3.9, Quartile: Q1)
World Journal of Gastrointestinal Oncology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.2)
World Journal of Hepatology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.1)
World Journal of Orthopedics (2024 released IF: 2.0, Quartile: Q2; CiteScore: 3.1)
World Journal of Gastrointestinal Surgery (2024 released IF: 1.8, Quartile: Q2)
World Journal of Stem Cells (2024 released IF: 3.6, Quartile: Q3; CiteScore: 7.8)
World Journal of Clinical Oncology (2024 released IF: 2.6, Quartile: Q3)
World Journal of Cardiology (2024 released IF: 1.9, Quartile: Q3; CiteScore: 3.3)
World Journal of Radiology (2024 released IF: 1.4, Quartile: Q3)
World Journal of Gastrointestinal Endoscopy (2024 released IF: 1.4, Quartile: Q4)"
-
El Kaouri I, Deligiannis I, Bakopoulou K, Sdralis PP, Shoumnalieva-Ivanova V, Shumnalieva R, Velikova T. Ophthalmological manifestations in autoimmune diseases: Overcoming diagnostic and therapeutic challenges. World J Exp Med 2025; 15(3): 104431 [DOI: 10.5493/wjem.v15.i3.104431]
|
|
23
|
-
"Congratulate ！The high-quality article performs well in terms of objectivity, credibility, and scientific quality. Thank you for your support of World Journal of Experimental Medicine. Looking forward to your next originality and innovativeness.
Impact Factors of Baishideng Series of Journals released in 2024:
World Journal of Gastroenterology (2024 released IF: 4.3, Quartile: Q1; CiteScore: 7.8)
World Journal of Diabetes (2024 released IF: 4.2, Quartile: Q1)
World Journal of Psychiatry (2024 released IF: 3.9, Quartile: Q1)
World Journal of Gastrointestinal Oncology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.2)
World Journal of Hepatology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.1)
World Journal of Orthopedics (2024 released IF: 2.0, Quartile: Q2; CiteScore: 3.1)
World Journal of Gastrointestinal Surgery (2024 released IF: 1.8, Quartile: Q2)
World Journal of Stem Cells (2024 released IF: 3.6, Quartile: Q3; CiteScore: 7.8)
World Journal of Clinical Oncology (2024 released IF: 2.6, Quartile: Q3)
World Journal of Cardiology (2024 released IF: 1.9, Quartile: Q3; CiteScore: 3.3)
World Journal of Radiology (2024 released IF: 1.4, Quartile: Q3)
World Journal of Gastrointestinal Endoscopy (2024 released IF: 1.4, Quartile: Q4)"
-
Gao N, Wu PF, Wu MW, Li YM, Liang X, Wang FF, Li XJ, Shen QQ, Zheng TP, Liu XL, Sun Y, Yang LX. PI3K/AKT/GSK3β regulatory axis in bone mesenchymal stem cells initiates diabetic myocardial infarction via miR-142-3p. World J Exp Med 2025; 15(3): 103948 [DOI: 10.5493/wjem.v15.i3.103948]
|
|
24
|
-
"Congratulate ！The high-quality article performs well in terms of objectivity, credibility, and scientific quality. Thank you for your support of World Journal of Experimental Medicine. Looking forward to your next originality and innovativeness.
Impact Factors of Baishideng Series of Journals released in 2024:
World Journal of Gastroenterology (2024 released IF: 4.3, Quartile: Q1; CiteScore: 7.8)
World Journal of Diabetes (2024 released IF: 4.2, Quartile: Q1)
World Journal of Psychiatry (2024 released IF: 3.9, Quartile: Q1)
World Journal of Gastrointestinal Oncology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.2)
World Journal of Hepatology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.1)
World Journal of Orthopedics (2024 released IF: 2.0, Quartile: Q2; CiteScore: 3.1)
World Journal of Gastrointestinal Surgery (2024 released IF: 1.8, Quartile: Q2)
World Journal of Stem Cells (2024 released IF: 3.6, Quartile: Q3; CiteScore: 7.8)
World Journal of Clinical Oncology (2024 released IF: 2.6, Quartile: Q3)
World Journal of Cardiology (2024 released IF: 1.9, Quartile: Q3; CiteScore: 3.3)
World Journal of Radiology (2024 released IF: 1.4, Quartile: Q3)
World Journal of Gastrointestinal Endoscopy (2024 released IF: 1.4, Quartile: Q4)"
-
Jialiken D, Dai J, Fan YD, Zhang HT, Shan JJ, Xu WC, Zou C. Gas chromatography-mass spectrometry-based plasma metabolomics analysis in hypertensive patients with Yin deficiency and Yang hyperactivity syndrome. World J Exp Med 2025; 15(3): 103154 [DOI: 10.5493/wjem.v15.i3.103154]
|
|
25
|
-
"Congratulate ！The high-quality article performs well in terms of objectivity, credibility, and scientific quality. Thank you for your support of World Journal of Experimental Medicine. Looking forward to your next originality and innovativeness.
Impact Factors of Baishideng Series of Journals released in 2024:
World Journal of Gastroenterology (2024 released IF: 4.3, Quartile: Q1; CiteScore: 7.8)
World Journal of Diabetes (2024 released IF: 4.2, Quartile: Q1)
World Journal of Psychiatry (2024 released IF: 3.9, Quartile: Q1)
World Journal of Gastrointestinal Oncology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.2)
World Journal of Hepatology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.1)
World Journal of Orthopedics (2024 released IF: 2.0, Quartile: Q2; CiteScore: 3.1)
World Journal of Gastrointestinal Surgery (2024 released IF: 1.8, Quartile: Q2)
World Journal of Stem Cells (2024 released IF: 3.6, Quartile: Q3; CiteScore: 7.8)
World Journal of Clinical Oncology (2024 released IF: 2.6, Quartile: Q3)
World Journal of Cardiology (2024 released IF: 1.9, Quartile: Q3; CiteScore: 3.3)
World Journal of Radiology (2024 released IF: 1.4, Quartile: Q3)
World Journal of Gastrointestinal Endoscopy (2024 released IF: 1.4, Quartile: Q4)"
-
Khan AS, Kamthan M, Ali A. Understanding the intricate interactions between microbiota and host. World J Exp Med 2025; 15(3): 101277 [DOI: 10.5493/wjem.v15.i3.101277]
|
|
26
|
-
"Congratulate ！The high-quality article performs well in terms of objectivity, credibility, and scientific quality. Thank you for your support of World Journal of Experimental Medicine. Looking forward to your next originality and innovativeness.
Impact Factors of Baishideng Series of Journals released in 2024:
World Journal of Gastroenterology (2024 released IF: 4.3, Quartile: Q1; CiteScore: 7.8)
World Journal of Diabetes (2024 released IF: 4.2, Quartile: Q1)
World Journal of Psychiatry (2024 released IF: 3.9, Quartile: Q1)
World Journal of Gastrointestinal Oncology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.2)
World Journal of Hepatology (2024 released IF: 2.5, Quartile: Q3; CiteScore: 4.1)
World Journal of Orthopedics (2024 released IF: 2.0, Quartile: Q2; CiteScore: 3.1)
World Journal of Gastrointestinal Surgery (2024 released IF: 1.8, Quartile: Q2)
World Journal of Stem Cells (2024 released IF: 3.6, Quartile: Q3; CiteScore: 7.8)
World Journal of Clinical Oncology (2024 released IF: 2.6, Quartile: Q3)
World Journal of Cardiology (2024 released IF: 1.9, Quartile: Q3; CiteScore: 3.3)
World Journal of Radiology (2024 released IF: 1.4, Quartile: Q3)
World Journal of Gastrointestinal Endoscopy (2024 released IF: 1.4, Quartile: Q4)"
-
Touzani S, Al-Waili N, Laaroussi H, Aboulghazi A, Hamas N, Imtara H, El Ghouizi A, ElArabi I, Al-Waili A, Lyoussi B. Effect of propolis and honey in hyperglycemia-induced kidney and liver injuries, proteinuria, and oxidant and antioxidant parameters. World J Exp Med 2025; 15(3): 99330 [DOI: 10.5493/wjem.v15.i3.99330]
|
|
27
|
-
"ESD is a very effective procedure for early-stage gastric cancer, but there are cases where metastasis occurs. The author scientifically examined many cases and came to the following conclusions, making this a very good paper.
A higher SRCC proportion is associated with smaller tumor size, less advanced T stages, fewer nodal or distant metastases, and reduced lymphatic, venous, and neural invasion. Particularly, the SRCC proportion in EGC should be validated as a significant factor in therapeutic approaches, including ESD.
"
-
Kim C, Lee HS, Na HY, Kwon HJ, Lee JA, Suh YS, Kang SH, Kim HH, Ahn SH, Oh HJ. Prognostic value of signet-ring cell carcinoma proportion in undifferentiated gastric cancer: Implications for endoscopic treatment decisions. World J Gastroenterol 2025; 31(30): 109465 [DOI: 10.3748/wjg.v31.i30.109465]
|
|
28
|
-
"The letter to the editor by Dimirli Atici S et al entitled "Integrating inflammation, nutrition, and artificial intelligence: A new era in colorectal cancer prognostic scoring" World J Gastroenterol 2025; 31(30): 108431 [DOI: 10.3748/wjg.v31.i30. 108431] discusses a critical issue for the coming years. These methods can help improve the prediction of survival in patients with CRC by increasing the rate of application of personalized treatments. The method discussed by the authors involves the integration of biochemical markers with artificial intelligence and is expected to significantly improve the quality of therapeutic decisions, thereby improving patient outcomes.
Medical science is a field in which artificial intelligence already offers a lot, and is expected to offer even more in the coming years. Of course, it is not likely to replace the decisions of the therapeutic team responsible for managing patients with CRC, but it will significantly help in making the right decisions. In my opinion, the period we are currently experiencing is likely to be a milestone for the future of medical science.
"
-
Demirli Atici S, Canda AE, Terzi MC. Integrating inflammation, nutrition, and artificial intelligence: A new era in colorectal cancer prognostic scoring. World J Gastroenterol 2025; 31(30): 108431 [DOI: 10.3748/wjg.v31.i30.108431]
|
|
29
|
-
"In this manuscript, the authors aimed to clarify the efficacy of measuring core-fucosylated low-molecular-weight kininogen (LMWK-Fc) for screening patients with liver fibrosis from normal volunteers. Although the performance in distinguishing between cases with and without fibrosis is largely affected by the distribution of fibrosis levels in patients with liver diseases, no data are provided showing this distribution. While the authors claimed that the correlation between LMWK-Fc and liver stiffness values was significant, the correlation coefficient was relatively low at 0.5789. The authors should demonstrate the distribution of this correlation by plotting the relationship. It would be difficult to utilize an indicator with a correlation coefficient of only 0.58. Furthermore, the authors attempted to establish the significance of LMWK-Fc by comparing its performance with other indicators, specifically gamma-glutamyl transferase and alkaline phosphatase, which are not established indicators for liver fibrosis. Therefore, it is difficult to confirm the efficacy of LMWK-Fc in evaluating liver fibrosis. Additionally, even if higher LMWK-Fc values result from the biological processes of fibrosis, these values may not indicate in which organ the fibrosis is occurring. Combined with poor English throughout (such as in the descriptions in the first paragraph of the introduction section), this manuscript may not provide useful information for the evaluation of liver fibrosis. "
-
Gao GF, Yu J, Tong L, Jiang D. Predictive value of core-fucosylated low-molecular-weight kininogen levels in patients with liver fibrosis: A prospective study. World J Gastroenterol 2025; 31(29): 105210 [DOI: 10.3748/wjg.v31.i29.105210]
|
|
30
|
-
"The study addresses the limitations of current diagnostic and surveillance methods for papillary thyroid cancer (PTC)—such as ultrasound, FNA, and thyroglobulin—and evaluates circulating miRNAs (miR-146, miR-221, miR-222) as promising non-invasive biomarkers. The authors followed PRISMA guidelines and used a clear flow diagram (Figure 1). Study quality was assessed using the QUADAS-2 tool, which is appropriate for diagnostic accuracy reviews (Table 3). The study separately evaluates PTC vs benign nodules and benign nodules vs healthy controls. This includes sensitivity, specificity, and false-positive rates for each miRNA, and highlights that miR-146 is most sensitive and miR-222 is most specific.
Limitations
Limited Number of Included Studies (n=6): Only six studies were included in the meta-analysis, with one from Europe and the rest from Asia. This raises concerns about geographic bias and limited generalizability.
Methodological Heterogeneity: All studies used different platforms for miRNA quantification (e.g., qPCR, microarray), leading to an “unclear risk” rating in the index test domain of QUADAS-2 for all included studies.
"
-
Dean B, Geropoulos G, Richardson-Jones T, Fornasiero M, Papapanou M, Konstantinidis C, Madouros N, Spinos D, Koimtzis G, Giannis D, Athanasiou C, Psarras K. Diagnostic accuracy of circulating miR-146, miR-221 and miR-222 in papillary thyroid cancer: A systematic review and meta-analysis. World J Clin Cases 2025; 13(27): 104916 [DOI: 10.12998/wjcc.v13.i27.104916]
|
|
31
|
-
"Thisa isa an excellant start to a full review of this topic. I suggest you consider perfrorming a systematic review to add to the literature, and update clinical scientists and clinicians. Perhaps you could direct your topic towrds "How therapies for inflammatory bowel disease are tailored based on the pdiffering pathogenesis of Crohn's disease and ulcerative colitis."
-
Agrawal H, Gupta N. Comparative analysis of the pathogenesis in Crohn’s disease and ulcerative colitis. World J Gastroenterol 2025; 31(29): 109892 [PMID: 40799370 DOI: 10.3748/wjg.v31.i29.109892]
|
|
32
|
-
"1. The typical sites of involvement can be mentioned- sole, scalp, back
2. The drug of choice can be mentioned with dosing, frequency
3. A characteristic histopathology / photomicrograph can be included for better understanding
4. Those with HIV positivity can have adverse drug reaction / toxicity due to sulfonamides, may require alternatives
5. Other common differentials can be listed - Actinomycosis, sporotrichosis"
-
Nagoba BS, Dhotre SV, Gavkare AM, Mumbre SS, Dhotre PS. Cutaneous nocardiosis in chronic renal insufficiency: Diagnostic and therapeutic considerations. World J Clin Cases 2025; 13(26): 108211 [DOI: 10.12998/wjcc.v13.i26.108211]
|
|
33
|
-
"1. What were the differentials after clinical examination?
2. Was there a change in weight / significant weight loss / anorexia?
3. Were the bowel loops displaced by the mass? Any great vessel encasement noted on imaging?
Was the mass well encapsulated on imaging and intra op?
4. What is the evidence to consider the diagnosis of Liposarcoma rather than lipoma?
5. What was the dose of adjuvant RT?"
-
Cheng LL, Tang B, Liu H, Zhu F, Chen YF, Zhang W. Thoughts and challenges of giant retroperitoneal liposarcoma: A case report. World J Clin Cases 2025; 13(26): 108308 [DOI: 10.12998/wjcc.v13.i26.108308]
|
|
34
|
-
"1. Were all malignant lesions considered?
2. How were infective causes such as infective / viral myocarditis ruled out?
3. Were the groups evaluated for significant difference in age?
4. Was the maximum tolerable dose limit exceeded in the cases?
5. The numbers do not tally - "the final sample comprised 194 patients." The table shows 195 pts
6. What were the study limitations?"
-
Méndez-Toro A, Muñoz-Rossi FA, Tejada-Cabrera RE, Rojas-Ruiz IT, Flechas-Ardila JD, García-Gutiérrez A, Novoa-Álvarez RA. Monitoring high-risk patients for chemotherapy-related cardiotoxicity: A retrospective analysis. World J Clin Cases 2025; 13(26): 107716 [DOI: 10.12998/wjcc.v13.i26.107716]
|
|
35
|
-
"1. Did the pt undergo periodic cystoscopy evaluation as part of the follow up?
2. Was a lesser radical procedure considered, given the size of the lesion, lack of local spread, and the age?
3. Did the pt satisfactorily complete adjuvant therapy the first time , 10 years back?
4. Any other options available which can reduce the chance of second malignancy - continent heterotopic pouch / colonic patch aument?
"
-
Murakami M, Noguchi H, Matsushita R, Tatarano S, Kirishima M, Tasaki T, Kitazono I, Higashi M, Enokida H, Tanimoto A. Urothelial carcinoma arising in orthotopic ileal neobladder reconstruction: A case report. World J Clin Cases 2025; 13(26): 104876 [DOI: 10.12998/wjcc.v13.i26.104876]
|
|
36
|
-
"1. The small sample size is a limitation
2. The assessment can be included as an objective parameter
3. The inclusion / exclusion criteria can be more elaborate
4. Exclusion of relevant psychiatric / somatic disorders to be included
5. Was use of medication / drugs considered as a subgroup analysis?
6. Were age, gender confounding factors in the study?
"
-
Jeong HW, Jung JW, Jang SH, Kim DY, Lee JY, Jang JS. Effects of driving simulator intervention on post-traumatic stress disorder symptoms after traffic accidents: A single-subject study. World J Clin Cases 2025; 13(26): 100363 [DOI: 10.12998/wjcc.v13.i26.100363]
|
|
37
|
-
"The need for the development of non-invasive tests in chronic hepatitis of either etiology is necessary. The power and limitations of the study conducted by Peta et al. are discussed well in this letter. To reach the targets of individualized medicine in AIH, the patient's multi omics data should be integrated in the upcoming assessment models. "
-
Jerez Diaz D, Twohig P. Toward non-invasive assessment strategies in autoimmune hepatitis. World J Hepatol 2025; 17(7): 107881 [PMID: 40747215 DOI: 10.4254/wjh.v17.i7.107881]
|
|
38
|
-
"This is an interesting case report. Autoimmune diseases might be seen in CLL. Although the patient has no risk factor for viral hepatitis, I check the viral load in such a case. Diagnosing the viral hepatitis by measuring the antibody levels could be misleading in CLL. Moreover, there is no data regarding the serum HBc antibody level in this case. Biochemical response include the normalization of gamma globulin level and serum IgG levels (No data was provided in this report). I would be glad if there was long term follow up data including the histologic response."
-
Giacomelli M, Carotti S, Vozella F, Pagliei F, Taffon C, Baiocchini A, Gambaro FL, Picardi A, Vespasiani-Gentilucci U, Galati G. Autoimmune hepatitis with syncytial giant cells in chronic lymphocytic leukemia: A case report and literature review. World J Hepatol 2025; 17(7): 106253 [PMID: 40747220 DOI: 10.4254/wjh.v17.i7.106253]
|
|
39
|
-
"In this editorial manuscript, the authors summarize both established and experimental endoscopic approaches aimed at improving metabolic states in metabolic dysfunction-associated fatty liver disease. These approaches target pathways such as the gut-islet axis, gut-brain axis, intestinal microbiota and its metabolites, as well as mechanisms involving nutrient restriction and malabsorption. The procedures are concisely described, with particular emphasis on a key study involving duodenal mucosal ablation using electroporation. In addition to discussing the efficacy of each method, the authors' presentation of limitations and future directions is informative and valuable. "
-
Fernandez CJ, Jena S, Lakshmi V, Pappachan JM. Duodenal mucosal ablation: An emerging therapeutic concept for metabolic dysfunction-associated fatty liver disease. World J Gastroenterol 2025; 31(28): 109468 [PMID: 40741478 DOI: 10.3748/wjg.v31.i28.109468]
|
|
40
|
-
"Indeed, with liver cirrhosis, both morphofunctional restructuring of the hepatic vasculature and complex splanchnic and systemic hemodynamic disturbance occur, contributing to the development of severe complications. In children, due to the rarity of liver cirrhosis, these disorders are rare, and therefore, the number of publications is small. I read with interest the article by Tambucci et al. The authors presented a well-structured review based on the current understanding of this pressing issue."
-
Tambucci R, Stephenne X, Channaoui A, de Magnée C. Liver and systemic hemodynamics in cirrhotic children. World J Hepatol 2025; 17(7): 103179 [PMID: 40747235 DOI: 10.4254/wjh.v17.i7.103179]
|
|
41
|
-
"Fecal transplants have been reported to improve the intestinal flora and improve UC and Crohn’s disease. In recent years, it has been reported that improving the intestinal flora improves liver damage. This is very interesting data, and it is believed that improving the intestinal flora improves bile acids and liver function. Please explain the mechanism behind this."
-
Ma L, Zhang MH, Xu YF, Hao YX, Niu XX, Li Y, Xing HC. Fecal microbiota transplantation: A promising treatment strategy for chronic liver disease. World J Gastroenterol 2025; 31(28): 105089 [PMID: 40741477 DOI: 10.3748/wjg.v31.i28.105089]
|
|
42
|
-
"The article “Stem cell therapy for diabetes: Advances, prospects, and challenges” provides a concise and informative overview of current developments in stem cell–based approaches to treating diabetes, with a particular focus on induced pluripotent stem cells (iPSCs), mesenchymal stem cells (MSCs), and pancreatic islet transplantation. Zuo et al. present the current state of research, acknowledging both the exciting advancements and the persistent challenges. However, in some cases, the discussion leans toward emphasizing successful studies and positive trial outcomes, occasionally lacking a rigorous critique of failures or contradictory findings in the field. Thus, many of the cited studies report favorable outcomes, with limited discussion of trials that yielded null results or failed to translate to clinical efficacy.
Authors clearly explain the underlying biological mechanisms, such as β-cell differentiation and paracrine immunomodulation by MSCs. Noteworthy advances are documented, including CRISPR-mediated immune evasion strategies, the development of encapsulation technologies to protect transplanted cells from host immunity, and the application of bioprinting to improve islet viability and function. The authors effectively describe the transition from basic research to clinical application, citing the first-in-human trials and the survival of stem cell–derived islets for over one year in patients. These contributions add clarity and momentum to the translational landscape of regenerative diabetes therapies.
Authors also acknowledges unresolved issues that remain major barriers to clinical translation. These include the risks of tumorigenicity associated with iPSCs, the low engraftment efficiency of transplanted cells, and ongoing challenges with host immune rejection. Furthermore, the absence of long-term safety and efficacy data from randomized controlled trials highlights the need for more rigorous evidence before widespread adoption. The authors propose future directions such as 3D bioprinting of organoids, AI-guided combination therapies, and further refinement of genome editing techniques to enhance safety and immune compatibility.
In conclusion, this review offers a well-informed and timely synthesis of the rapidly evolving field of stem cell therapy for diabetes. It successfully highlights promising technologies and recent clinical breakthroughs while acknowledging the complexity of translating laboratory innovations into durable, safe, and accessible therapies. Future iterations of this work would benefit from deeper critical analysis of contradictory evidence, expanded discussion on regulatory and ethical frameworks, and integration of emerging clinical trial data. Such enhancements would further strengthen its contribution to the scientific community and aid in shaping the direction of next-stage research and therapeutic development."
-
Zuo DB, Wang CH, Sang M, Sun XD, Chen GP, Ji KK. Stem cell therapy for diabetes: Advances, prospects, and challenges. World J Diabetes 2025; 16(7): 107344 [PMID: 40697599 DOI: 10.4239/wjd.v16.i7.107344]
|
|
43
|
-
"There is an Ethical problems, because hepatic hemangioma is benign tumor and it does not require any treatment. Transcatheter arterial chemoembolization (TACE) and microwave ablation (MWA) have an adverse events, and so authors should make clear the definition of hepatic hemangioma which needs treatment. Authors only described the prognosis after 12 months. Authors should report the longer prognosis.
"
-
Sun JP, Zhou K, Pan J, Yang N, Sun XN, Zhao HT, Yang XB. Efficacy and safety of transcatheter arterial chemoembolization combined with microwave ablation for hepatic hemangiomas (> 5 cm). World J Gastroenterol 2025; 31(28): 109078 [PMID: 40741475 DOI: 10.3748/wjg.v31.i28.109078]
|
|
44
|
-
"Well written manuscript, providing a detailed overview of MPox in neonates, including clinical presentation and particularities in this age group, diagnosis, treatment options and therapeutic considerations, public health challenges and future implications. Specific mention of differential diagnostic consideration is also appreciated.
Reference list is relevant and complete and the quality of language is good.
Although I understand that MPox is rare in children, I'd suggest if possible to add some statements on the current epidemiology of MPox in this age group, or if it is only limited to case reports.
"
-
Ikram E, Shaukat A, Qureshi MS, Saifullah M, Aslam MA, Mehdi AM. Monkeypox in neonates: A narrative review on clinical presentations, vertical transmission, and treatment challenges. World J Clin Infect Dis 2025; 14(1): 109806 [DOI: 10.5495/wjcid.v14.i1.109806]
|
|
45
|
-
"Vonoprazan (VPZ) is a new potassium antagonist that inhibits gastric acid secretion by blocking the binding of H+/K+-ATPase to K+ and preventing the entry of H+ into the gastric lumen. Existing studies demonstrate that VPZ-based treatment regimens, including triple therapy regimens with VPZ, amoxicillin, and clarithromycin, are both safe and effective in eradicating H. pylori. The multicenter randomized controlled trial discussed here was the first to compare triple therapy based on VPZ (VPZ/amoxicillin/clarithromycin) with the 14-day quadruple regimen based on bismuth in China. The results showed that triple therapy with VPZ achieved higher eradication rates compared to the quadruple regimen and with similar rates of side effects, making triple therapy with VPZ an important alternative (without bismuth) for eradicating H. pylori. Interestingly, no significant differences in eradication rates were observed between the 10- and 14-day treatments. However, to optimize results and reduce the incidence of antibiotic resistance, it is necessary to conduct extensive, multicenter studies in various countries worldwide."
-
Han RS, Hao JW, Wang T, Xin Z, Fan GX, Wang GD, Liu MM, Liu CX, Yang QZ, Yang ZW, Lv XY, Zhang C, Bian G, Meng J, Cui ZQ, Yun XJ, Cao JH, Li SH, Fan JF, Ma HG, Gao FY, Mao T, Tian ZB, Song XH, Yu YN. Efficacy and safety of triple therapy with vonoprazan for Helicobacter pylori eradication: A multicenter, prospective, randomized controlled trial. World J Gastroenterol 2025; 31(28): 109001 [PMID: 40741473 DOI: 10.3748/wjg.v31.i28.109001]
|
|
46
|
-
"The minireview "Key players in the breast cancer microenvironment: From fibroblasts to immune cells" by Sacide et al summarizes the role of tumor microenvironment in the immune invasion, therapy resistance and metastasis process in Breast cancer. This understanding will definitely help us to explore the breast cancer progression with new therapeutic approach. The minireview is well written and beautifully presented. The language and grammar is appropriate. The referencing is good.
However, a description on role of tumor microenvironment on angiogenesis and angiogenic signaling could have been discussed.
Overall The review is good and useful for the scientific community."
-
Çakal S, Er Urgancı B, Şimşek S. Key players in the breast cancer microenvironment: From fibroblasts to immune cells. World J Clin Oncol 2025; 16(7): 107339 [PMID: 40741191 DOI: 10.5306/wjco.v16.i7.107339]
|
|
47
|
-
"This study concerns a consensus reached by a group of experts from the Middle East, who, with the assistance of an internationally recognized German expert, formulated comprehensive guidelines on the treatment of Helicobacter pylori infection in the Middle East. It is well known that the prevalence of Helicobacter pylori infection in these countries is quite high in both adults and children. The development of antibiotic resistance in these countries is another obstacle to the effectiveness of treatment. In this sense, the formulation of these guidelines for treating Helicobacter pylori infection is useful and of practical importance, particularly about the risk of developing gastric cancer. Such activities should also be carried out in other parts of the world (e.g., Africa, Asia)."
-
Sharara AI, Alsohaibani FI, Alsaegh A, Al Ejji K, Al Awadhi S, Malfertheiner P, Karam SA, Al-Taweel T. First regional consensus on the management of Helicobacter pylori infection in the Middle East. World J Gastroenterol 2025; 31(27): 107138 [PMID: 40741103 DOI: 10.3748/wjg.v31.i27.107138]
|
|
48
|
-
"This is very interesting paper about heart failure after TIPS.Heart failure can be a complication after a transjugular intrahepatic portosystemic shunt (TIPS) procedure, particularly in patients with pre-existing heart conditions or those with cirrhotic cardiomyopathy. While post-TIPS heart failure is relatively uncommon, it is crucial to understand the factors that can contribute to its development and to monitor patients closely for signs and symptoms. The author's fig4 EKG, BNP, and echocardiographic evaluations are simple and easy to understand."
-
Tomassoni DR, Schildkraut T, Ramachandran V, Cooke JC, Sawhney R. Cardiovascular risk assessment and predictors of cardiac decompensation after transjugular intrahepatic portosystemic shunt in patients with cirrhosis. World J Gastroenterol 2025; 31(27): 107740 [PMID: 40741106 DOI: 10.3748/wjg.v31.i27.107740]
|
|
49
|
-
"Kwon et al. reported that deep learning-based localization and lesion detection in capsule endoscopy for patients with suspected small-bowel bleeding. It maybe true the AI-based localization and lesion detection is very useful for the discovery of small-bowel bleeding in patients.
If possible, authors should distribute these application for everyone examine their figures. If so, everyone could recognize the results of authors."
-
Kwon YS, Park TY, Kim SE, Park Y, Lee JG, Lee SP, Kim KO, Jang HJ, Yang YJ, Cho BJ. Deep learning-based localization and lesion detection in capsule endoscopy for patients with suspected small-bowel bleeding. World J Gastroenterol 2025; 31(27): 106819 [PMID: 40741104 DOI: 10.3748/wjg.v31.i27.106819]
|
|
50
|
-
"Excellently presented study. All points are very well taken. The article provides a comprehensive perspective on all contemporary aspects of variceal hemorrhage management. The article is written so that it is recommended for gastroenterologists, general surgeons, hospitalists, and emergency medicine physicians. The Authors' effort constitutes a major contribution towards updating the current knowledge and understanding of the problem, and provides a foundation for database perfection.
"
-
Kogilathota Jagirdhar GS, Okafor CC, Hussain M, Elmati PR, Ghumman A, Shah M, Surani S. Decline of the Sengstaken-Blakemore tube: A review of shifting practices in gastrointestinal hemorrhage management. World J Crit Care Med 2025; 14(3): 101856 [DOI: 10.5492/wjccm.v14.i3.101856]
|
